McCartney, Daniel LStevenson, Anna JWalker, Rosie MGibson, JudeMorris, Stewart WCampbell, ArchieMurray, Alison DWhalley, Heather CPorteous, David JMcIntosh, Andrew MEvans, Kathryn LDeary, Ian JMarioni, Riccardo E2018-10-032018-10-032018McCartney, D L, Stevenson, A J, Walker, R M, Gibson, J, Morris, S W, Campbell, A, Murray, A D, Whalley, H C, Porteous, D J, McIntosh, A M, Evans, K L, Deary, I J & Marioni, R E 2018, 'Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease', Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, vol. 10, pp. 429-437. https://doi.org/10.1016/j.dadm.2018.05.0062352-8729PubMedCentral: PMC6111045ORCID: /0000-0003-4915-4847/work/76976580http://hdl.handle.net/2164/11211This work was supported by a Alzheimer's Research UK Major Project grant (ARUK-PG2017B-10). Generation Scotland received core funding from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006). We are grateful to all the families who took part, the general practitioners and the Scottish School of Primary Care for their help in recruiting them, and the whole Generation Scotland team that includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, health-care assistants and nurses. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland, and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award “STratifying Resilience and Depression Longitudinally” [STRADL];104036/Z/14/Z). DNA methylation data collection was funded by the Wellcome Trust Strategic Award (10436/Z/14/Z). The research was conducted in the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the cross-council Lifelong Health and Wellbeing Initiative (MR/K026992/1); funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged. CCACE supports I.J.D. with some additional support from the Dementias Platform UK (MR/L015382/1). A.M.M. and H.C.W. have received support from the Sackler Institute.9522525engDNA METHYLATIONEpigenetic clockAlzheimer's diseasegeneticsGeneration ScotlandR MedicineAlzheimers Research UKARUK-PG2017B-10Chief Scientist Office (CSO)CZD/16/6Wellcome Trust104036/Z/14/ZMedical Research Council (MRC)MR/K026992/1MR/L015382/1Biotechnology and Biological Sciences Research Council (BBSRC)RJournal article10.1016/j.dadm.2018.05.00610